These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25256751)

  • 21. Identifying Candidate Druggable Targets in Canine Cancer Cell Lines Using Whole-Exome Sequencing.
    Das S; Idate R; Cronise KE; Gustafson DL; Duval DL
    Mol Cancer Ther; 2019 Aug; 18(8):1460-1471. PubMed ID: 31175136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annotation of Variant Data from High-Throughput DNA Sequencing from Tumor Specimens: Filtering Strategies to Identify Driver Mutations.
    Sun S; Thorson JA; Murray SS
    Methods Mol Biol; 2019; 1908():49-60. PubMed ID: 30649720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-exome sequencing to identify novel somatic mutations in squamous cell lung cancers.
    Zheng CX; Gu ZH; Han B; Zhang RX; Pan CM; Xiang Y; Rong XJ; Chen X; Li QY; Wan HY
    Int J Oncol; 2013 Sep; 43(3):755-64. PubMed ID: 23799614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model.
    Maguire SL; Peck B; Wai PT; Campbell J; Barker H; Gulati A; Daley F; Vyse S; Huang P; Lord CJ; Farnie G; Brennan K; Natrajan R
    J Pathol; 2016 Nov; 240(3):315-328. PubMed ID: 27512948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine.
    Nagahashi M; Wakai T; Shimada Y; Ichikawa H; Kameyama H; Kobayashi T; Sakata J; Yagi R; Sato N; Kitagawa Y; Uetake H; Yoshida K; Oki E; Kudo SE; Izutsu H; Kodama K; Nakada M; Tse J; Russell M; Heyer J; Powers W; Sun R; Ring JE; Takabe K; Protopopov A; Ling Y; Okuda S; Lyle S
    Genome Med; 2016 Dec; 8(1):136. PubMed ID: 28007036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding oncogenicity of cancer driver genes and mutations in the cancer genomics era.
    Porta-Pardo E; Valencia A; Godzik A
    FEBS Lett; 2020 Dec; 594(24):4233-4246. PubMed ID: 32239503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.
    Cheng F; Zhao J; Zhao Z
    Brief Bioinform; 2016 Jul; 17(4):642-56. PubMed ID: 26307061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic analysis of mutation distribution in three dimensional protein structures identifies cancer driver genes.
    Fujimoto A; Okada Y; Boroevich KA; Tsunoda T; Taniguchi H; Nakagawa H
    Sci Rep; 2016 May; 6():26483. PubMed ID: 27225414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iatrogenic endometriosis harbors somatic cancer-driver mutations.
    Lac V; Verhoef L; Aguirre-Hernandez R; Nazeran TM; Tessier-Cloutier B; Praetorius T; Orr NL; Noga H; Lum A; Khattra J; Prentice LM; Co D; Köbel M; Mijatovic V; Lee AF; Pasternak J; Bleeker MC; Krämer B; Brucker SY; Kommoss F; Kommoss S; Horlings HM; Yong PJ; Huntsman DG; Anglesio MS
    Hum Reprod; 2019 Jan; 34(1):69-78. PubMed ID: 30428062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.
    Nickerson ML; Witte N; Im KM; Turan S; Owens C; Misner K; Tsang SX; Cai Z; Wu S; Dean M; Costello JC; Theodorescu D
    Oncogene; 2017 Jan; 36(1):35-46. PubMed ID: 27270441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data.
    do Valle ÍF; Giampieri E; Simonetti G; Padella A; Manfrini M; Ferrari A; Papayannidis C; Zironi I; Garonzi M; Bernardi S; Delledonne M; Martinelli G; Remondini D; Castellani G
    BMC Bioinformatics; 2016 Nov; 17(Suppl 12):341. PubMed ID: 28185561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of constrained cancer driver genes based on mutation timing.
    Sakoparnig T; Fried P; Beerenwinkel N
    PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DriverDB: an exome sequencing database for cancer driver gene identification.
    Cheng WC; Chung IF; Chen CY; Sun HJ; Fen JJ; Tang WC; Chang TY; Wong TT; Wang HW
    Nucleic Acids Res; 2014 Jan; 42(Database issue):D1048-54. PubMed ID: 24214964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of accumulated alterations in driver and passenger genes on response to radiation therapy.
    Seo Y; Tamari K; Takahashi Y; Minami K; Isohashi F; Suzuki O; Sumida I; Ogawa K
    Br J Radiol; 2020 May; 93(1109):20190625. PubMed ID: 32031414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating growth patterns and driver effects in tumor evolution from individual samples.
    Salichos L; Meyerson W; Warrell J; Gerstein M
    Nat Commun; 2020 Feb; 11(1):732. PubMed ID: 32024824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: A proof of principle study.
    Bubien V; Bonnet F; Dupiot-Chiron J; Barouk-Simonet E; Jones N; de Reynies A; MacGrogan G; Sevenet N; Letouzé E; Longy M
    Genes Chromosomes Cancer; 2017 Nov; 56(11):788-799. PubMed ID: 28691344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why Are Some Driver Mutations Rare?
    Nussinov R; Tsai CJ; Jang H
    Trends Pharmacol Sci; 2019 Dec; 40(12):919-929. PubMed ID: 31699406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beyond the exome: the role of non-coding somatic mutations in cancer.
    Piraino SW; Furney SJ
    Ann Oncol; 2016 Feb; 27(2):240-8. PubMed ID: 26598542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
    Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
    J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency.
    Wang L; Tsutsumi S; Kawaguchi T; Nagasaki K; Tatsuno K; Yamamoto S; Sang F; Sonoda K; Sugawara M; Saiura A; Hirono S; Yamaue H; Miki Y; Isomura M; Totoki Y; Nagae G; Isagawa T; Ueda H; Murayama-Hosokawa S; Shibata T; Sakamoto H; Kanai Y; Kaneda A; Noda T; Aburatani H
    Genome Res; 2012 Feb; 22(2):208-19. PubMed ID: 22156295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.